Table of Contents 
Epilepsy Research and Treatment
Volume 2011 (2011), Article ID 758407, 11 pages
http://dx.doi.org/10.1155/2011/758407
Research Article

Characterization of the Gene Expression Profile of Human Hippocampus in Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis

Julio Lachos,1,2,3 Michela Zattoni,1 Heinz-Gregor Wieser,3 Jean-Marc Fritschy,4 Thomas Langmann,5 Gerd Schmitz,5 Mariella Errede,6 Daniela Virgintino,6 Yasuhiro Yonekawa,1 and Karl Frei1

1Department of Neurosurgery, University Hospital Zurich, 8091 Zurich, Switzerland
2Department of Neurology, University Hospital Zurich, 8091 Zurich, Switzerland
3Department of Psychiatry, University Hospital Zurich, Culmannstrasse 8, 8091 Zurich, Switzerland
4Institute of Pharmacology and Toxicology, University of Zurich, 8057 Zurich, Switzerland
5Institute for Clinical Chemistry, University of Regensburg, 93040 Regensburg, Germany
6Department of Human Anatomy and Histology, Medical School, Bari University, 70124 Bari, Italy

Received 2 September 2010; Revised 10 December 2010; Accepted 1 January 2011

Academic Editor: Giangennaro Coppola

Copyright © 2011 Julio Lachos et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. G. Wieser, M. Ortega, A. Friedman, and Y. Yonekawa, “Long-term seizure outcomes following amygdalohippocampectomy,” Journal of Neurosurgery, vol. 98, no. 4, pp. 751–763, 2003. View at Google Scholar · View at Scopus
  2. H. G. Wieser, “Mesial temporal lobe epilepsy with hippocampal sclerosis,” Epilepsia, vol. 45, no. 6, pp. 695–714, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. W. Löscher, “Mechanism of drug resistance,” Epileptic Disorders, vol. 1, pp. 3–9, 2008. View at Google Scholar
  4. G. Regesta and P. Tanganelli, “Clinical aspects and biological bases of drug-resistant epilepsies,” Epilepsy Research, vol. 34, no. 2-3, pp. 109–122, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Schmidt and W. Löscher, “Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms,” Epilepsia, vol. 46, no. 6, pp. 858–877, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. L. J. Stephen, P. Kwan, and M. J. Brodie, “Does the cause of localisation-related epilepsy influence the response to antiepileptic drug treatment?” Epilepsia, vol. 42, no. 3, pp. 357–362, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Oby and D. Janigro, “The blood-brain barrier and epilepsy,” Epilepsia, vol. 47, no. 11, pp. 1761–1774, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. N. C. de Lanerolle and T. S. Lee, “New facets of the neuropathology and molecular profile of human temporal lobe epilepsy,” Epilepsy and Behavior, vol. 7, no. 2, pp. 190–203, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. J. L. Jankowsky and P. H. Patterson, “The role of cytokines and growth factors in seizures and their sequelae,” Progress in Neurobiology, vol. 63, no. 2, pp. 125–149, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Vezzani, D. Moneta, C. Richichi, C. Perego, and M. G. De Simoni, “Functional role of proinflammatory and anti-inflammatory cytokines in seizures,” Advances in Experimental Medicine and Biology, vol. 548, pp. 123–133, 2004. View at Google Scholar · View at Scopus
  11. S. F. Berkovic and G. D. Jackson, “The hippocampal sclerosis whodunit: enter the genes,” Annals of Neurology, vol. 47, no. 5, pp. 557–558, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Kanemoto, J. Kawasaki, T. Miyamoto, H. Obayashi, and M. Nishimura, “Interleukin (IL)-1β, IL-1α, and IL-1 receptor antagonist gene polymorphisms in patients with temporal lobe epilepsy,” Annals of Neurology, vol. 47, no. 5, pp. 571–574, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Dubé, A. Vezzani, M. Behrens, T. Bartfai, and T. Z. Baram, “Interleukin-1β contributes to the generation of experimental febrile seizures,” Annals of Neurology, vol. 57, no. 1, pp. 152–155, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. W. M. Pardridge, J. Eisenberg, and T. Yamada, “Rapid sequestration and degradation of somatostatin analogues by isolated brain microvessels,” Journal of Neurochemistry, vol. 44, no. 4, pp. 1178–1184, 1985. View at Google Scholar · View at Scopus
  15. L. A. Repesh and T. J. Fitzgerald, “Interactions of tumor cells with intact capillaries: a model for intravasation,” Clinical and Experimental Metastasis, vol. 2, no. 2, pp. 139–150, 1984. View at Google Scholar · View at Scopus
  16. E. Hubbell, W. M. Liu, and R. Mei, “Robust estimators for expression analysis,” Bioinformatics, vol. 18, no. 12, pp. 1585–1592, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Langmann, R. Mauerer, and G. Schmitz, “Human ATP-binding cassette transporter TaqMan low-density array: analysis of macrophage differentiation and foam cell formation,” Clinical Chemistry, vol. 52, no. 2, pp. 310–313, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Aronica, J. A. Gorter, G. H. Jansen et al., “Expression and cellular distribution of multidrug transporter proteins in two major causes of medically intractable epilepsy: focal cortical dysplasia and glioneuronal tumors,” Neuroscience, vol. 118, no. 2, pp. 417–429, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. S. M. Dombrowski, S. Y. Desai, M. Marroni et al., “Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy,” Epilepsia, vol. 42, no. 12, pp. 1501–1506, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Kubota, H. Ishihara, T. Langmann et al., “Distribution and functional activity of P-glycoprotein and multidrug resistance-associated proteins in human brain microvascular endothelial cells in hippocampal sclerosis,” Epilepsy Research, vol. 68, no. 3, pp. 213–228, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. S. M. Sisodiya, “Mechanisms of antiepileptic drug resistance,” Current Opinion in Neurology, vol. 16, no. 2, pp. 197–201, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. D. M. Tishler, K. I. Weinberg, D. R. Hinton, N. Barbaro, G. M. Annett, and C. Raffel, “MDR1 gene expression in brain of patients with medically intractable epilepsy,” Epilepsia, vol. 36, no. 1, pp. 1–6, 1995. View at Publisher · View at Google Scholar · View at Scopus
  23. A. J. Becker, J. Chen, S. Paus et al., “Transcriptional profiling in human epilepsy: expression array and single cell real-time qRT-PCR analysis reveal distinct cellular gene regulation,” NeuroReport, vol. 13, no. 10, pp. 1327–1333, 2002. View at Google Scholar · View at Scopus
  24. A. J. Becker, J. Chen, A. Zien et al., “Correlated stage- and subfield-associated hippocampal gene expression patterns in experimental and human temporal lobe epilepsy,” European Journal of Neuroscience, vol. 18, no. 10, pp. 2792–2802, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. C. G. Bien, U. Gleissner, R. Sassen, G. Widman, H. Urbach, and C. E. Elger, “An open study of tacrolimus therapy in Rasmussen encephalitis,” Neurology, vol. 62, no. 11, pp. 2106–2109, 2004. View at Google Scholar · View at Scopus
  26. T. Ravizza, B. Gagliardi, F. Noé, K. Boer, E. Aronica, and A. Vezzani, “Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy,” Neurobiology of Disease, vol. 29, no. 1, pp. 142–160, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Vezzani and T. Z. Baram, “New roles for interleukin-1β in the mechanisms of epilepsy,” Epilepsy Currents, vol. 4, pp. 45–50, 2007. View at Google Scholar
  28. A. Vezzani, S. Balosso, and T. Ravizza, “The role of cytokines in the pathophysiology of epilepsy,” Brain, Behavior, and Immunity, vol. 22, no. 6, pp. 797–803, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. M. D. Nguyen, J. P. Julien, and S. Rivest, “Innate immunity: the missing link in neuroprotection and neurodegeneration?” Nature Reviews Neuroscience, vol. 3, no. 3, pp. 216–227, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Vezzani and T. Granata, “Brain inflammation in epilepsy: experimental and clinical evidence,” Epilepsia, vol. 46, no. 11, pp. 1724–1743, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. E. A. Van Vliet, S. D. C. Araújo, S. Redeker, R. Van Schaik, E. Aronica, and J. A. Gorter, “Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy,” Brain, vol. 130, no. 2, pp. 521–534, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Bauer, S. Cepok, A. Todorova-Rudolph et al., “Etiology and site of temporal lobe epilepsy influence postictal cytokine release,” Epilepsy Research, vol. 86, no. 1, pp. 82–88, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Vezzani and D. Janigro, “Leukocyte-endothelial adhesion mechanism in epilepsy: cheers and jeers,” Epilepsy Currents, vol. 9, pp. 118–221, 2009. View at Google Scholar
  34. A. Vezzani, S. Balosso, M. Maroso, D. Zardoni, F. Noé, and T. Ravizza, “ICE/caspase 1 inhibitors and IL-1β receptor antagonists as potential therapeutics in epilepsy,” Current Opinion in Investigational Drugs, vol. 11, no. 1, pp. 43–50, 2010. View at Google Scholar · View at Scopus